BTA shareholders should be asking Peter Cook why he has to talk...

BTA shareholders should be asking Peter Cook why he has to talk down the share price.

Even when he reported exciting news on the tripling of production capacity and the rotahaler he introduced “uncertainties” using words like “may be” including posting negative conditions deliberately to dampen the good news.

The increase in Relenza sales has nothing to do with Peter Cook the idiot. GSK's performance is put to shame by Roche's performance.

Quote:
While the positive effect of this expansion on Biota may be significant and GSK have confirmed it has contracts to supply Relenza to over 60 countries, the announcement is focussed on increased manufacturing capacity for Relenza, not orders or sales.
GSK has stated that additional regulatory approvals will be required and that the capacity increases are planned for the end of calendar 2009. The expansion of Relenza capacity and any increase in resultant royalty payments, will not effect Biota’s cash position until June 2010, at the earliest.

For more details read these posts:
http://www.hotcopper.com.au/post_single.asp?fid=1&tid=945681&msgid=5269681

http://www.hotcopper.com.au/post_single.asp?fid=1&tid=944330&msgid=5263917

http://www.hotcopper.com.au/post_single.asp?fid=1&tid=936783&msgid=5217474

http://www.hotcopper.com.au/post_single.asp?fid=1&tid=922627&msgid=5136853